Sada Sharada Tumor And Research Institute - Company Profile

It is a healthcare public not for profit company based in Karnataka, Karnataka, India, established in 1989.
1989 Karnataka, Karnataka, India Active
Last Updated:
Access Report
About Sada Sharada Tumor And Research Institute

Sada Sharada Tumor And Research Institute, a active public not for profit company, was established on 20 February 1989 in Karnataka, Karnataka, India. Engaging in preventive health services within the hospital and medical care sector, it holds CIN: U85110KA1989NPL009862. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹6.00 Cr and a paid-up capital of ₹5.98 Cr.

It upholds a compliant status. Employing 260 professional, Its leadership includes Basavlinga Amarkumar (Director), Anjali Rossi Ajaikumar (Director), Basavalinga Ajaikumar Sadasivaiah (Director). Past directors included Narasimhan Suryanarayanarao. It holds ₹4.25 Cr open charges and ₹4.70 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 438, Hebbal Areamysore Karnataka, Karnataka, Karnataka, 560017.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85110KA1989NPL009862

  • Registration Number

    009862

  • Incorporation Date

    20 February 1989

  • Authorized Capital

    ₹6.00 Cr

  • Paid-Up Capital

    ₹5.98 Cr

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 6.00 Cr
  • Paid Up Capital ₹ 5.98 Cr
  • Company Age 37 Year, 8 Days
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 4.25 Cr
  • Satisfied Charges ₹ 4.70 M
  • Revenue Growth **** 26.34%
  • Profit Growth **** -20.14%
  • Ebitda **** 114.75%
  • Net Worth 22.23%
  • Total Assets **** 12.86%
Company report

Sada Sharada Tumor And Research Institute

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Sada Sharada Tumor And Research Institute — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Sada Sharada Tumor And Research Institute?
Current Directors
Name Designation Appointment Date Status
Basavlinga Amarkumar Director 20 Feb 1989 Current
Anjali Rossi Ajaikumar Director 19 Mar 2018 Current
Basavalinga Ajaikumar Sadasivaiah Director 20 Feb 1989 Current
Bhagya Adaveesh Ajaikumar Director 30 Sep 1993 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Company Secretary - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sada Sharada Tumor And Research Institute.

Sada Sharada Tumor And Research Institute, for the financial year ended 2023, experienced significant growth in revenue, with a 26.34% increase. The company also saw a substantial fall in profitability, with a 20.14% decrease in profit. The company's net worth Soared by an impressive increase of 22.23%.

Sada Sharada Tumor And Research Institute revenue growth over time
Sada Sharada Tumor And Research Institute profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 26.34%
*******
*******
*******
*******
Revenue from Operations
*******
 48.26%
*******
*******
*******
*******
Total Assets
*******
 12.86%
*******
*******
*******
*******
Profit or Loss
*******
 -20.14%
*******
*******
*******
*******
Net Worth
*******
 22.23%
*******
*******
*******
*******
EBITDA
*******
 114.75%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sada Sharada Tumor And Research Institute?

In 2023, Sada Sharada Tumor And Research Institute had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹42,500,000.00

Satisfied Charges

₹4,700,000.00

Charges Breakdown by Lending Institutions
  • Yes Bank Limited : 4.25 Cr
Latest Charge Details
Date Lender Amount Status
14 Mar 2023 Yes Bank Limited ₹4.25 Cr Open
26 Nov 2013 Syndicate Bank ₹4.70 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Sada Sharada Tumor And Research Institute?

Sada Sharada Tumor And Research Institute has a workforce of 260 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sada Sharada Tumor And Research Institute, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sada Sharada Tumor And Research Institute's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sada Sharada Tumor And Research Institute
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Sada Sharada Tumor And Research Institute last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.

  • Balance Sheet

    Sada Sharada Tumor And Research Institute has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was recorded as a recent event.

  • Charges

    The activity A charge with Yes Bank Limited amounted to Rs. 4.25 Cr with Charge ID 100687089 was registered on 14 Mar 2023. was completed.

  • Charges

    A charge registered on 26 Nov 2013 via Charge ID 10463010 with Syndicate Bank was fully satisfied on 28 Oct 2022. was recorded as a recent event.

  • Director Appointment

    Anjali Rossi Ajaikumar was appointed as a Director was appointed as a Director on 19 Mar 2018 & has been associated with this company since 7 years 11 months . was recorded as a recent event.

  • Charges

    The activity A charge with Syndicate Bank amounted to Rs. 0.47 Cr with Charge ID 10463010 was registered on 26 Nov 2013. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Sada Sharada Tumor And Research Institute?

The CIN of Sada Sharada Tumor And Research Institute is U85110KA1989NPL009862.

Where is Sada Sharada Tumor And Research Institute headquartered?

Sada Sharada Tumor And Research Institute is headquartered at 438, Hebbal Areamysore Karnataka, Karnataka, Karnataka, 560017.

When was Sada Sharada Tumor And Research Institute incorporated?

Sada Sharada Tumor And Research Institute was incorporated on 20 February 1989.

Who are the current directors of Sada Sharada Tumor And Research Institute?

The current directors of Sada Sharada Tumor And Research Institute are

What is the primary industry of Sada Sharada Tumor And Research Institute?

The primary industry of Sada Sharada Tumor And Research Institute is Hospital And Medical Care.

Is Sada Sharada Tumor And Research Institute a listed company?

Sada Sharada Tumor And Research Institute is unlisted.

What is the capital structure of Sada Sharada Tumor And Research Institute?

The authorized capital of Sada Sharada Tumor And Research Institute is ₹6.00 Cr, and the paid-up capital is ₹5.98 Cr.

What is the compliance status of Sada Sharada Tumor And Research Institute?

The compliance status of Sada Sharada Tumor And Research Institute is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available